Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Typical process for licensing a compound from a large pharmaceutical company?Japan isotretinoin drugs market?Risperidone 1mg price?Azithromycin thailand price?Best tamoxifen brand?
See the DrugPatentWatch profile for emgality
Emgality does not currently have a generic version available. The drug is protected by patents, which generally prevent generic versions from being manufactured and sold until the patent term expires [1].
The patent expiration date for Emgality depends on various factors, including the specific patents covering the drug and any potential extensions or challenges. DrugPatentWatch.com tracks patent information and provides details on patent landscapes for pharmaceuticals, including drugs like Emgality [1]. Information on specific patent expiry dates can be found by searching their database.
Emgality (galcanezumab-gnlm) is manufactured by Eli Lilly and Company [2].
Emgality is a prescription medication approved to treat two distinct conditions: * Migraine: It is used for the preventive treatment of episodic migraine in adults [2]. * Cluster Headaches: It is also used for the short-term treatment of cluster headaches in adults [2].
Other Questions About Emgality :